- Home
- ENX vs DERM Comparison
ENX vs DERM Comparison
Compare ENX & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENX
- DERM
- Stock Information
- Founded
- ENX 2002
- DERM 2014
- Country
- ENX United States
- DERM United States
- Employees
- ENX N/A
- DERM N/A
- Industry
- ENX Finance/Investors Services
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- ENX Finance
- DERM Health Care
- Exchange
- ENX Nasdaq
- DERM Nasdaq
- Market Cap
- ENX 169.0M
- DERM 165.6M
- IPO Year
- ENX N/A
- DERM 2021
- Fundamental
- Price
- ENX $9.39
- DERM $7.47
- Analyst Decision
- ENX
- DERM Strong Buy
- Analyst Count
- ENX 0
- DERM 2
- Target Price
- ENX N/A
- DERM $12.50
- AVG Volume (30 Days)
- ENX 25.4K
- DERM 192.3K
- Earning Date
- ENX 01-01-0001
- DERM 08-12-2025
- Dividend Yield
- ENX 3.94%
- DERM N/A
- EPS Growth
- ENX N/A
- DERM N/A
- EPS
- ENX 0.16
- DERM N/A
- Revenue
- ENX N/A
- DERM $56,397,000.00
- Revenue This Year
- ENX N/A
- DERM $28.99
- Revenue Next Year
- ENX N/A
- DERM $52.61
- P/E Ratio
- ENX $61.00
- DERM N/A
- Revenue Growth
- ENX N/A
- DERM N/A
- 52 Week Low
- ENX $7.84
- DERM $3.54
- 52 Week High
- ENX $10.07
- DERM $8.90
- Technical
- Relative Strength Index (RSI)
- ENX 57.20
- DERM 53.23
- Support Level
- ENX $9.28
- DERM $6.70
- Resistance Level
- ENX $9.48
- DERM $7.25
- Average True Range (ATR)
- ENX 0.11
- DERM 0.44
- MACD
- ENX 0.00
- DERM -0.04
- Stochastic Oscillator
- ENX 22.77
- DERM 35.87
About ENX Eaton Vance New York Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance New York Municipal Bond Fund is principally engaged in managing investment funds and providing investment management and advisory services to high-net-worth individuals and institutions. It is a non-diversified, closed-end investment company. Its objective is to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in specified state.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.